HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common stock, $.01 par value per share
Shares outstanding
46,480,294
Total 13F shares
50,792,206
Share change
+202,598
Total reported value
$4,551,407,114
Put/Call ratio
12%
Price per share
$89.58
Number of holders
294
Value change
+$20,351,169
Number of buys
131
Number of sells
154

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q3 2023

As of 30 Sep 2023, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 294 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,792,206 shares. The largest 10 holders included Capital Research Global Investors, BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, FRANKLIN RESOURCES INC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, and ROYCE & ASSOCIATES LP. This page lists 294 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.